Gastroenterological Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Vascular Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Eur J Vasc Endovasc Surg. 2022 Dec;64(6):646-653. doi: 10.1016/j.ejvs.2022.07.006. Epub 2022 Aug 2.
The exact incidence and outcomes of acute occlusive arterial mesenteric ischaemia (AMI) are unclear as most studies include only patients diagnosed correctly while alive. The aim of this study was to assess the incidence, mortality, and diagnostics of AMI by also including patients diagnosed post-mortem.
This retrospective study comprised patients diagnosed with AMI either alive or post-mortem between 2006 and 2015 within a healthcare district serving 1.6 million inhabitants. Key exclusion criteria were venous or non-obstructive ischaemia.
A total of 470 patients were included in the study of which 137 (29%) were diagnosed post-mortem. The most common misdiagnoses on those not diagnosed alive were unspecified infection (n = 19, 17%), gastrointestinal bleeding (n = 13, 11%), and ileus (n = 13, 11%). Of those diagnosed alive (n = 333), 187 (56%) underwent active surgical or endovascular treatment. During the 2006 - 2015 period, the overall incidence of AMI was 3.05 (95% CI 2.78 - 3.34)/100 000 person years and 26.66 (95% CI 24.07 - 29.45) for those aged 70 years or more. The mean autopsy rate during the study period was 29% for the overall population (32% during 2006 - 2010 and 25% during 2011 - 2015) and 18% for those aged 70 years or more. Overall, the 90-day mortality was 83% in all patients. The ninety day mortality decreased, being 87% during the first period (2006 - 2010) and 79% during the second period (2011 - 2015) (p = .029), while at the same time the proportion of patients diagnosed alive rose from 71% to 80% (p = .030) and the number of endovascular revascularisations rose from 1% to 5% (p = .022).
A significant proportion of patients with AMI are not diagnosed alive, which is reflected in the mortality rates. Post-mortem examinations and autopsy rate data continue to be key factors in epidemiological studies on AMI.
由于大多数研究仅包括存活时正确诊断的患者,因此急性闭塞性肠系膜动脉缺血(AMI)的确切发病率和结局尚不清楚。本研究的目的是通过纳入死后诊断的患者,评估 AMI 的发病率、死亡率和诊断方法。
本回顾性研究纳入了 2006 年至 2015 年期间在一个为 160 万居民提供服务的医疗保健区中,通过生前或死后诊断为 AMI 的患者。主要排除标准为静脉或非阻塞性缺血。
本研究共纳入 470 例患者,其中 137 例(29%)为死后诊断。那些生前未确诊的最常见的误诊为未特指感染(n=19,17%)、胃肠道出血(n=13,11%)和肠梗阻(n=13,11%)。在生前诊断的 333 例患者中,187 例(56%)接受了积极的手术或血管内治疗。在 2006-2015 年期间,AMI 的总体发病率为 3.05(95%CI 2.78-3.34)/100000 人年,70 岁及以上人群为 26.66(95%CI 24.07-29.45)。研究期间的平均尸检率为总人口的 29%(2006-2010 年期间为 32%,2011-2015 年期间为 25%),70 岁及以上人群为 18%。总体而言,所有患者的 90 天死亡率为 83%。90 天死亡率下降,第一阶段(2006-2010 年)为 87%,第二阶段(2011-2015 年)为 79%(p=0.029),而同时,生前诊断的患者比例从 71%上升到 80%(p=0.030),血管内再血管化的数量从 1%上升到 5%(p=0.022)。
相当一部分 AMI 患者未被生前诊断,这反映在死亡率中。死后检查和尸检率数据仍然是 AMI 流行病学研究的关键因素。